Roisin O'Cearbhaill

28PUBLICATIONS
175CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCommercial lawMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 11, 2026
Seasonal variation and risk of paclitaxel-induced hypersensitivity reactions: A retrospective cohort study.

|Jul 27, 2026
Outpatient rapid drug desensitisation for chemotherapy and biologic agents: high success rates in a large single-centre cohort study.

|May 29, 2026
Novel combination of immunotherapy and tyrosine kinase inhibitor for recurrent cervical cancer: balancing efficacy and toxicity.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|May 01, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Mar 05, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

Ramez N Eskander, Michael W Sill, Lindsey Beffa

Pageof 5

Frequent Collaborators

5 joint publications

Britta Weigelt

5 joint publications

William P Tew

5 joint publications

Qin Zhou

5 joint publications

Alexia Iasonos